Boston Scientific Corp.

BSX

Boston Scientific Corporation (BSX) is a global medical device company specializing in innovative healthcare solutions. Founded in 1979, it develops and manufactures devices for cardiovascular, respiratory, digestive, and other medical conditions, focusing on minimally invasive procedures and improving patient outcomes.

$44.03 -0.42 (-0.94%)
🚫 Boston Scientific Corp. does not pay dividends

Company News

Disposable Endoscopes Market Size Projected to Hit USD 10.47 Billion by 2035 | SNS Insider
GlobeNewswire Inc. • Sns Insider • July 13, 2026

The global disposable endoscopes market is expected to expand at a CAGR of 15.04% through 2035, driven by rising infection prevention initiatives, adoption of single-use endoscopes, and minimally invasive procedures. North America leads with 38.45% market share, while Asia Pacific records the fastest growth. Hospitals dominate the end-user segmen...

Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider
GlobeNewswire Inc. • Sns Insider • June 27, 2026

The global brain implants market, valued at USD 7.10 billion in 2025, is projected to reach USD 18.39 billion by 2035, growing at a CAGR of 9.99%. Growth is driven by rising prevalence of neurological disorders and increasing adoption of deep brain stimulation, neuromodulation systems, and brain-computer interfaces. North America leads the market...

Microcatheter Market Size to Reach USD 1.79 Billion by 2035 | SNS Insider
GlobeNewswire Inc. • Sns Insider • June 19, 2026

The global microcatheter market is valued at USD 1.05 billion in 2025 and is projected to reach USD 1.79 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by increasing adoption of minimally invasive cardiovascular and neurovascular procedures, rising prevalence of cardiovascular and neurovascular disorders, and advancements in cath...

Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months
The Motley Fool • Thomas Niel • June 13, 2026

Boston Scientific shares have plummeted over 50% year-to-date due to repeated downward guidance revisions, particularly regarding declining Watchman procedure usage. Despite bearish market sentiment, 27 of 31 analysts maintain buy ratings with a consensus price target of $78 (65% upside), though the article cautions this recovery may be challengi...

Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031
GlobeNewswire Inc. • Researchandmarkets.Com • June 2, 2026

The global peripheral vascular devices market is projected to grow from USD 10.02 billion in 2026 to USD 13.22 billion by 2031 at a CAGR of 5.7%, driven by rising prevalence of vascular disorders, aging populations, and innovations in minimally invasive devices. Asia Pacific is expected to see the highest growth, with major players including Bost...

Related Companies